Medaphor Group PLC Investor presentation
07 February 2018 - 6:00PM
RNS Non-Regulatory
TIDMMED
Medaphor Group PLC
07 February 2018
MedaPhor Group plc
("MedaPhor" or the "Group" or the "Company")
Investor presentation
MedaPhor Group plc (AIM: MED), the intelligent ultrasound
software and simulation company, announces that it will be
presenting at the Shares and AJ Bell Spotlight Evening in London on
Tuesday 13 February 2018.
The Shares and AJ Bell Investor evening provides an opportunity
for Directors to make a presentation and talk about their company
business plans for 2018 direct to existing and potential
investors.
The event will commence at 6pm at Novotel Tower Bridge, London,
EC3N 2NR. At the event CEO Stuart Gall will deliver a presentation
detailing the Company's strategy following the recent acquisition
of Intelligent Ultrasound Limited, along with an overview of the
Company, where it is currently positioned and their plans for the
future.
If you are interested in attending the event and would like
information on how to register please contact Walbrook PR at
medaphor@walbrookpr.com
The presentation will contain no new material information and is
available on the Company's website:
http://investors.medaphor.com/
Enquiries:
MedaPhor Group plc www.medaphor.com
Stuart Gall, CEO Tel: +44 (0)29 2075
Nicholas Sleep, CTO 6534
Cenkos Securities Tel: +44 (0)20 7397
8900
Camilla Hume/Bobbie Hilliam
(Nominated Advisor)
Michael Johnson / Julian
Morse (Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780 or
medaphor@walbrookpr.com
Paul McManus / Anna Mob: +44 (0)7980 541 893 / Mob:
Dunphy +44 (0)7876 741 001
About MedaPhor (www.medaphor.com)
MedaPhor (AIM: MED), the intelligent ultrasound software and
simulation company, develops advanced hi-fidelity haptic and
manikin based training simulators, clinical image analysis software
tools, augmented reality based needle guidance software and
artificial intelligence based automated scanning software for all
medical practitioners.
Based in Cardiff and Oxford in the UK and Atlanta in the US,
MedaPhor is split into two divisions:
Ultrasound Simulation and Training
Focuses on hi-fidelity ultrasound education and training through
simulation. Its three main products are the ScanTrainer(TM) OBGYN
and General Medical simulator training platform, the HeartWorks(TM)
echocardiography simulator platform and the BodyWorks Eve(TM)
Point-of-Care simulator platform (launching January 2018). Over 500
MedaPhor simulators have been sold to over 300 medical institutions
in over 30 countries around the world.
Intelligent Ultrasound
Focuses on developing augmented reality and deep-learning based
algorithms to make ultrasound machines smarter and more accessible.
ScanNav(TM) uses machine-learning based algorithms to automatically
identify and grade ultrasound images to provide scan assessment and
audit of obstetric scanning. NeedleGuide(TM) aims to simplify
ultrasound-guided needling by using deep learning and augmented
reality to provide the user with pathway guidance and automated
tracking for a range of medical procedures.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAEAXAKELAPEFF
(END) Dow Jones Newswires
February 07, 2018 02:00 ET (07:00 GMT)
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Apr 2024 to May 2024
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From May 2023 to May 2024